An Integrated Care Platform Based on the Monitoring of Older Individual Intrinsic Capacity for Inclusive Health (CAREUP)
Launched by ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI · Jul 25, 2023
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The CAREUP trial is studying a new platform designed to help older adults live better at home. This platform uses various tools like tablets, smartwatches, and sensors to gather information about the health and daily activities of older individuals. The goal is to see if this technology can improve their quality of life and make it easier for them to manage their health independently.
To participate in this trial, individuals must be able to live independently at home, be in good physical and mental health, and be capable of using smartphones or tablets on their own. Unfortunately, those with certain medical conditions, like severe heart problems or significant cognitive impairments, will not be eligible. If chosen, participants will have the chance to use the CAREUP platform and help researchers understand how effective it is in supporting older adults' health and well-being. This trial is not yet recruiting participants, so there will be more information available soon about how to get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Live independently in their home in rural or urban areas;
- • In good physical and cognitive status;
- • Able to stand and walk unaided;
- • Availability to sign the Informed Consent;
- • Ability to use smartphones/tablets independently.
- Exclusion Criteria:
- • Use of active implant or not-implant medical devices;
- • Allergy to nickel components;
- • Lack of written informed consent;
- • Acute or untreated medical problems such as history of syncopal episodes, epilepsy and vertigo not controlled pharmacologically; serious dysfunction of the autonomic system; severe behavioural syndromes not compensated by drugs; concurrent neurological diseases; severe systemic diseases with life expectancy \< 1 year;
- • A myocardial infarction or stroke within 6 months;
- • Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;
- • Uncontrolled hypertension;
- • Pacemaker or implantable cardioverter defibrillator;
- • Diagnosis of mild and or/advanced Parkinson's disease or other neuromuscular disorder;
- • Diagnosis of mild and/or advance cognitive impairments
- • Metastatic cancer or immunosuppressive therapy;
- • Significant visual or hearing impairment
About Istituto Nazionale Di Ricovero E Cura Per Anziani
The Istituto Nazionale di Ricovero e Cura per Anziani (INRCA) is a prominent Italian research institute dedicated to the care and rehabilitation of the elderly. As a leading sponsor of clinical trials, INRCA focuses on advancing medical knowledge and improving health outcomes for older adults through innovative research methodologies. The institute collaborates with various healthcare professionals and academic institutions to conduct studies that address critical geriatric health issues, emphasizing a multidisciplinary approach to enhance the quality of life for seniors. With a commitment to ethical research practices and patient-centered care, INRCA plays a vital role in shaping the future of elderly healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ancona, , Italy
Vienna, , Austria
Bucharest, , Romania
Patients applied
Trial Officials
Vera Stara
Study Chair
IRCCS INRCA, Ancona, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported